www.fdanews.com/articles/108833-fda-approves-shire-rsquo-s-vyvanse-for-adult-adhd-sufferers

FDA Approves Shire’s Vyvanse for Adult ADHD Sufferers

July 23, 2008

Shire began selling Vyvanse as a treatment for adults with attention deficit hyperactivity disorder.
Philadelphia Business Journal